S Araki

1.8k total citations
49 papers, 1.5k citations indexed

About

S Araki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, S Araki has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in S Araki's work include Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers), Respiratory and Cough-Related Research (4 papers) and Cerebral Venous Sinus Thrombosis (4 papers). S Araki is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers), Respiratory and Cough-Related Research (4 papers) and Cerebral Venous Sinus Thrombosis (4 papers). S Araki collaborates with scholars based in Japan and Russia. S Araki's co-authors include Masaru Ando, Manabu Sugimoto, Y Hitoshi, Ryoji Matsumoto, A Tominaga, Kiyoshi Takatsu, Shuji Mita, Sumiko Ijiri, Hiroshi Maeda and Takaaki Akaike and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

S Araki

43 papers receiving 1.4k citations

Peers

S Araki
Comparison fields: 5 of 104
  • Molecular Biology 622
  • Immunology 448
  • Physiology 303
  • Cell Biology 193
  • Epidemiology 148
Replace W. Vogt with:
W. Vogt Germany
John McClary United States
G P Jahreis United States
C.F.A. CULLING Canada
Ilkka Mononen Finland
G. Bensi Italy
Adam J. Smolka United States
Shohko Tsunawaki Japan
Rasmus Larsen Portugal
Klaus Vosbeck Switzerland
W. Vogt Germany View profile →
Citations per field, relative to S Araki
S Araki · 1×
Citations per year, relative to S Araki
S Araki · 1×

Countries citing papers authored by S Araki

Since Specialization
Citations

This map shows the geographic impact of S Araki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Araki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Araki more than expected).

Fields of papers citing papers by S Araki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Araki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Araki. The network helps show where S Araki may publish in the future.

Co-authorship network of co-authors of S Araki

This figure shows the co-authorship network connecting the top 25 collaborators of S Araki. A scholar is included among the top collaborators of S Araki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Araki. S Araki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Anticoagulant activity of the novel thrombin inhibitor 1-butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl) amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride.
1
2 3
3 26
4 45
5 21
6 49
7 24
8 288
9 327
10
[A case of ischemic oculopathy followed by border zone infarction].
1
11 20
12
Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells.
58
13 4
14
Experimental hypersensitivity pneumonitis in rabbits induced by Trichosporon cutaneum: role of local cellular and humoral immune responses.
4
15
[Type I familial amyloidotic polyneuropathy].
3
16
IgM cold-reactive lymphocytotoxin from sera in patients with sarcoidosis.
0
17
Preventive and reverse effects of nifedipine on human bronchoconstriction "in vitro".
7
18 22
19
[Pathological study of familial primary amyloidosis with peripheral and autonomic nervous disorders as a main symptom, with special reference to 2 autopsy cases and literature review].
1
20 168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026